[Federal Register Volume 88, Number 117 (Tuesday, June 20, 2023)]
[Notices]
[Pages 39853-39854]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13063]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifier: CMS-10398 #64]


Medicaid and Children's Health Insurance Program (CHIP) Generic 
Information Collection Activities: Proposed Collection; Comment Request

AGENCY: Centers for Medicare & Medicaid Services, Health and Human 
Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: On May 28, 2010, the Office of Management and Budget (OMB) 
issued Paperwork Reduction Act (PRA) guidance related to the 
``generic'' clearance process. Generally, this is an expedited process 
by which agencies may obtain OMB's approval of collection of 
information requests that are ``usually voluntary, low-burden, and 
uncontroversial collections,'' do not raise any substantive or policy 
issues, and do not require policy or methodological review. The process 
requires the submission of an overarching plan that defines the scope 
of the individual collections that would fall under its umbrella. On 
October 23, 2011, OMB approved our initial request to use the generic 
clearance process under control number 0938-1148 (CMS-10398). It was 
last approved on April 26, 2021, via the standard PRA process which 
included the publication of 60- and 30-day Federal Register notices. 
The scope of the April 2021 umbrella accounts for Medicaid and CHIP 
State plan amendments, waivers, demonstrations, and reporting. This 
Federal Register notice seeks public comment on one or more of our 
collection of information requests that we believe are generic and fall 
within the scope of the umbrella. Interested persons are invited to 
submit comments regarding our burden estimates or any other aspect of 
this collection of information, including: the necessity and utility of 
the proposed information collection for the proper performance of the 
agency's functions, the accuracy of the estimated burden, ways to 
enhance the quality, utility and clarity of the information to be 
collected, and the use of automated collection techniques or other 
forms of information technology to minimize the information collection 
burden.

DATES: Comments must be received by July 5, 2023.

ADDRESSES: When commenting, please reference the applicable form number 
(see below) and the OMB control number (0938-1148). To be assured 
consideration, comments and recommendations must be submitted in any 
one of the following ways:
    1. Electronically. You may send your comments electronically to 
http://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection document(s) that are accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development, Attention: CMS-10398 (#64)/OMB 
control number: 0938-1148, Room C4-26-05, 7500 Security Boulevard, 
Baltimore, Maryland 21244-1850.
    To obtain copies of a supporting statement and any related forms 
for the proposed collection(s) summarized in this notice, please access 
the CMS PRA website by copying and pasting the following web address 
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.

FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.

SUPPLEMENTARY INFORMATION: Following is a summary of the use and burden 
associated with the subject information collection(s). More detailed 
information

[[Page 39854]]

can be found in the collection's supporting statement and associated 
materials (see ADDRESSES).

Generic Information Collection

    1. Title of Information Collection: Medicaid Section 1115 Substance 
Use Disorder (SUD) Demonstration: Federal Meta-Analysis Support; Type 
of Information Collection Request: Revision of a currently approved 
collection; Use: Starting in 2015, in response to the opioid epidemic, 
CMS offered states the flexibility to test Medicaid coverage of a full 
substance use disorder (SUD) treatment service array in the context of 
overall SUD service delivery transformation through the authority of 
section 1115 demonstrations. In 2017, CMS modified the requirements for 
SUD section 1115 demonstrations to improve access to clinically 
appropriate treatment for OUD and other SUDs, to better support the 
development and expansion of comprehensive treatment strategies, and to 
incorporate improved progress and outcome monitoring. In 2018, CMS 
awarded the Federal Meta-Analysis Support contract to RTI International 
to understand the overall effectiveness of the groups of demonstrations 
with similar features and how variations in state demonstration 
features and the context in which they are implemented contribute to 
differences in effectiveness. The meta-analysis includes multiple 
rounds of qualitative data collection consisting of: characteristics 
interviews, implementation interviews, and provider interviews. This 
2023 iteration increases the number of respondents. We are not revising 
any of our active reporting instruments. Form Number: CMS-10398 (#64) 
(OMB control number: 0938-1148); Frequency: Once; Affected Public: 
State, Local, or Tribal Governments, and the Private sector; Number of 
Respondents: 60; Total Annual Responses: 340; Total Annual Hours: 405. 
For policy questions regarding this collection contact: Paula Kazi at 
(240) 841-4332.

    Dated: June 14, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and 
Regulatory Affairs.
[FR Doc. 2023-13063 Filed 6-16-23; 8:45 am]
BILLING CODE 4120-01-P